FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Luger

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Phenomena

Ultraviolet Rays

Disorders

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Agatha Stegemann; Adriana del Rey; Beate Eckes; Bernd L Fiebich; Sergei A Grando; Alexander Heinick; Thomas A Luger; Frank U Müller; Karin Scharffetter-Kochanek; Jan S Schulte; Anca Sindrilaru; Markus Böhm
Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Nikolaos Patsinakidis; Christian Surber; Joerg Wenzel; Joachim Gerss; Raphael Koch; Aysche Landmann; Thomas A Luger; Dieter Metze; Annegret Kuhn
Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls.
Markus Böhm; Thomas A Luger; Ulrike Raap; Rainer H Straub; Tomasz Wasiewicz; Michal A Zmijewski; Andrzej Slominski
KU812 basophils express urocortin, CRH-R, MC1R and steroidogenic enzymes and secrete progesterone.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Luger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Agatha Stegemann; Adriana del Rey; Beate Eckes; Bernd L Fiebich; Sergei A Grando; Alexander Heinick; Thomas A Luger; Frank U Müller; Karin Scharffetter-Kochanek; Jan S Schulte; Anca Sindrilaru; Markus Böhm
Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Arthritis and rheumatism 2013;65(3):792-804.
2012: Nikolaos Patsinakidis; Christian Surber; Joerg Wenzel; Joachim Gerss; Raphael Koch; Aysche Landmann; Thomas A Luger; Dieter Metze; Annegret Kuhn
Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls.
Experimental dermatology 2012;21(12):958-61.
2012: Markus Böhm; Thomas A Luger; Ulrike Raap; Rainer H Straub; Tomasz Wasiewicz; Michal A Zmijewski; Andrzej Slominski
KU812 basophils express urocortin, CRH-R, MC1R and steroidogenic enzymes and secrete progesterone.
Experimental dermatology 2012;21(7):541-3.
2012: Matteo Auriemma; Thomas Brzoska; Tobias Goerge; Lars Klenner; Verena Kupas; Thomas A Luger; Tim D. Sparwasser; Maik Voskort; Zuotao Zhao; Karin Loser
α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation.
The Journal of investigative dermatology 2012;132(7):1814-24.
2012: Markus Böhm; Randolf Brehler; Britta Eiz-Vesper; Manuela Gehring; Helmut Haas; Kerstin Jurk; Alexander Kapp; Thomas A Luger; Ralf Paus; Evgeni Ponimaskin; Koji Sugawara; Andrew F Walls; Mara Apel; Ulrike Raap
Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone.
The Journal of allergy and clinical immunology 2012;129(4):1085-93.
2012: M C Ohlmeier; H Traupe; Thomas A Luger; M Böhm
Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(4):503-7.
2012: Volker Meyer; Alexander Friedrich; Nina Kerk; Thomas A Luger; Alexander Mellmann; Tobias Goerge
MRSA eradication in dermatologic outpatients - theory and practice.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2012;10(3):186-96.
2011: Martin Steinhoff; Mathias Sulk; Jerome Aubert; Jörg Buddenkotte; Isabelle Carlavan; Ferda Cevikbas; Sophie Déret; Thomas A Luger; Christian Mess; Dieter Metze; Pawel Novak; Michel Rivier; Carine Rosignoli; Verena D Schwab; Johannes J Voegel
Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2011;15(1):2-11.
2011: Dominik Bettenworth; Markus Böhm; Thomas Brzoska; Marion Buyse; Isabel Czorniak; Wolfram Domschke; Klaus Kannengiesser; Torsten Kucharzik; Thomas A Luger; Christian Maaser; Rudolf Mennigen; Andreas Lügering
The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function.
The American journal of pathology 2011;179(3):1230-42.
2011: Ferdinand Toberer; Stefan Beissert; Alexander Enk; Daniel Göttel; Wolfgang Hartschuh; Stefan Joos; Peter H Krammer; Karin Loser; Thomas A Luger; Vincent Ruland; Jaromir Sykora; Annegret Kuhn
Tissue microarray analysis of RANKL in cutaneous lupus erythematosus and psoriasis.
Experimental dermatology 2011;20(7):600-2.
2011: Annegret Kuhn; Percy Lehmann; Thomas A Luger; Peter Reitmeir; Vincent Ruland; Gisela Bonsmann; Noemi Gaebelein-Wissing; Kristina Gensch; Merle Haust; Stefan W Schneider; Annette Wons; Thomas Ruzicka
Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial.
Journal of the American Academy of Dermatology 2011;65(1):54-64, 64.e1-2.
2011: Volker Meyer; Tobias Goerge; Thomas A Luger; Stefan Beissert
Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.
The Journal of clinical and aesthetic dermatology 2011;4(4):45-6.
2011: Verena Kupas; Carsten Weishaupt; Dorothee Siepmann; Maria-Laura Kaserer; Mareike Eickelmann; Dieter Metze; Thomas A Luger; Stefan Beissert; Karin Loser
RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.
The Journal of investigative dermatology 2011;131(4):944-55.
2011: D Siepmann; Thomas A Luger; Carsten Weishaupt; Sonja Ständer
Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients.
Dermatology (Basel, Switzerland) 2011;223(4):374-80.
2010: Ngoc Quan Phan; Jeffrey D Bernhard; Thomas A Luger; Sonja Ständer
Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Journal of the American Academy of Dermatology 2010;63(4):680-8.
2010: A Kuhn; V Ruland; N Patsinakidis; Thomas A Luger
Use of methotrexate in patients with psoriasis.
Clinical and experimental rheumatology 2010;28(5 Suppl 61):S138-44.
2010: Annegret Kuhn; Thomas A Luger
Psoriasis: Is ustekinumab superior to etanercept for psoriasis?
Nature reviews. Rheumatology 2010;6(9):500-1.
2010: Arianna Mastrofrancesco; Agatha Kokot; Alex Eberle; Nicholas C J Gibbons; Karin U Schallreuter; Elwira Strozyk; Mauro Picardo; Christos C Zouboulis; Thomas A Luger; Markus Böhm
KdPT, a tripeptide derivative of alpha-melanocyte-stimulating hormone, suppresses IL-1 beta-mediated cytokine expression and signaling in human sebocytes.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(3):1903-11.
2010: Annegret Kuhn; A M Meuth; D Bein; S Amler; Stefan Beissert; Markus Böhm; R Brehler; Jan Ehrchen; S Grundmann; M Haust; V Ruland; Meinhard Schiller; P Schulz; Sonja Ständer; Cristina Sauerland; W Köpcke; Thomas A Luger; Gisela Bonsmann
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus.
The British journal of dermatology 2010;163(1):83-92.
2010: M Böhm; Thomas A Luger
[Alpha-melanocyte-stimulating hormone. From bench to bedside].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2010;61(6):497-504.
2010: Karin Loser; Thomas Vogl; Maik Voskort; Aloys Lueken; Verena Kupas; Wolfgang Nacken; Lars Klenner; Annegret Kuhn; Dirk Foell; Lydia Sorokin; Thomas A Luger; Johannes Roth; Stefan Beissert
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.
Nature medicine 2010;16(6):713-7.
2010: Sonja Ständer; Thomas A Luger
Itch in atopic dermatitis - pathophysiology and treatment.
Acta dermatovenerologica Croatica : ADC 2010;18(4):289-96.
2010: Sonja Ständer; Dorothee Siepmann; Ilka Herrgott; Cord Sunderkötter; Thomas A Luger
Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
PloS one 2010;5(6):e10968.
2010: Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.
PloS one 2010;5(2):e8958.
2010: Meinhard Schiller; Sylviane Dennler; Ulf Anderegg; Agatha Kokot; Jan C Simon; Thomas A Luger; Alain Mauviel; Markus Böhm
Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions.
The Journal of biological chemistry 2010;285(1):409-21.
2010: Peter Hensen; Rudolf Stadler; Thomas A Luger
The role and duties of scientific medical societies: The German Society of Dermatology from the member's perspective.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2010;8(1):20-31.
2009: Athanasios Tsianakas; Jan Ehrchen; Dagmar Presser; Tobias Fischer; Birgit Kruse-Loesler; Thomas A Luger; Cord Sunderkoetter
Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis.
Journal of the American Academy of Dermatology 2009;61(4):701-6.
2009: Bettina Ramser; Agatha Kokot; Dieter Metze; Nina Weiss; Thomas A Luger; Markus Böhm
Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts.
The Journal of investigative dermatology 2009;129(10):2419-26.
2009: Athanasios Tsianakas; Meinhard Schiller; Thomas A Luger; Cord Sunderkötter
The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2009;7(8):671-9.
2009: Thomas A Luger; J Barker; J Lambert; S Yang; D Robertson; J Foehl; C T Molta; R Boggs
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2009;23(8):896-904.
2009: Peter Hensen; Marcel Lucas Müller; Ramin Haschemi; Hartmut Ständer; Thomas A Luger; Cord Sunderkötter; Meinhard Schiller
Predisposing factors of actinic keratosis in a North-West German population.
European journal of dermatology : EJD 2009;19(4):345-54.
2009: S Schulz; M Metz; D Siepmann; Thomas A Luger; Marcus Maurer; Sonja Ständer
[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2009;60(7):564-8.
2009: G Hensen; M Schiller; Thomas A Luger; Peter Hensen
[Psychosocial issues in outpatient care of acne vulgaris].
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2009;71(7):405-13.
2009: Agatha Kokot; Dieter Metze; Nicolas Mouchet; Marie-Dominique Galibert; Meinhard Schiller; Thomas A Luger; Markus Böhm
Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin.
Endocrinology 2009;150(7):3197-206.
2009: Sonja Ständer; Stefan W Schneider; Carsten Weishaupt; Thomas A Luger; Laurent Misery
Putative neuronal mechanisms of sensitive skin.
Experimental dermatology 2009;18(5):417-23.
2009: Karin Loser; Andreas Sturm; Maik Voskort; Verena Kupas; Sandra Balkow; Matteo Auriemma; Carlo Sternemann; Axel U Dignass; Thomas A Luger; Stefan Beissert
Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(9):5419-29.
2009: Agatha Kokot; Anca Sindrilaru; Meinhard Schiller; Cord Sunderkötter; Claus Kerkhoff; Beate Eckes; Karin Scharffetter-Kochanek; Thomas A Luger; Markus Böhm
alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Arthritis and rheumatism 2009;60(2):592-603.
2009: Stefan Beissert; Sylvia Pauser; Michael Sticherling; Uta Frieling; Klaus-Dieter Loske; Peter J Frosch; Ingo Haase; Thomas A Luger
A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
Dermatology (Basel, Switzerland) 2009;219(2):126-32.
2009: Sonja Ständer; Barbara Böckenholt; Funda Schürmeyer-Horst; Carsten Weishaupt; Gereon Heuft; Thomas A Luger; Gudrun Schneider
Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.
Acta dermato-venereologica 2009;89(1):45-51.
2009: Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Nanomedicine--challenge and perspectives.
Angewandte Chemie (International ed. in English) 2009;48(5):872-97.
2008: Esther Pogatzki-Zahn; Martin Marziniak; Gudrun Schneider; Thomas A Luger; Sonja Ständer
Chronic pruritus: targets, mechanisms and future therapies.
Drug news & perspectives 2008;21(10):541-51.
2008: Dorothee Siepmann; Thomas A Luger; Sonja Ständer
Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6(11):941-6.
2008: Peter Hensen; Marcel Lucas Müller; Rudolf Stadler; Thomas A Luger
Dermatologic subspecialties in German inpatient dermatology:a national survey.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6(9):735-40.
2008: Gabriele Stengel; Dieter Metze; Bernd Dörflinger; Thomas A Luger; Markus Böhm
Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon.
Journal of the American Academy of Dermatology 2008;59(2 Suppl 1):S7-9.
2008: Thomas Brzoska; Thomas A Luger; Christian Maaser; Christoph Abels; Markus Böhm
Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.
Endocrine reviews 2008;29(5):581-602.
2008: Marcel Lucas Müller; Andrea Forschner; Andreas Wenke; Thomas A Luger; Rainer Rompel; Norbert Roeder; Peter Hensen
[G-DRG Version 2008: Facts and analyses].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6(6):483-91.
2008: Victoria M Shpacovitch; M Feld; Morley D Hollenberg; Thomas A Luger; Martin Steinhoff
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity.
Journal of leukocyte biology 2008;83(6):1309-22.
2008: Klaus Kannengiesser; Christian Maaser; Jan Heidemann; Andreas Luegering; Matthias Ross; Thomas Brzoska; Markus Bohm; Thomas A Luger; Wolfram Domschke; Torsten Kucharzik
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.
Inflammatory bowel diseases 2008;14(3):324-31.
2008: Sonja Ständer; Elke Weisshaar; Thomas A Luger
Neurophysiological and neurochemical basis of modern pruritus treatment.
Experimental dermatology 2008;17(3):161-9.
2008: Peter Hensen; S Beissert; L Bruckner-Tuderman; Thomas A Luger; Norbert Roeder; Marcel Lucas Müller
Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological setting.
European journal of public health 2008;18(1):85-91.
2008: Markus Böhm; Thomas A Luger; Gisela Bonsmann
Disseminated giant molluscum contagiosum in a patient with idiopathic CD4+ lymphocytopenia. Successful eradication with systemic interferon.
Dermatology (Basel, Switzerland) 2008;217(3):196-8.
2008: Carmen Loquai; Dorothee Nashan; Peter Hensen; Thomas A Luger; Stephan Grabbe; Cord Sunderkötter; Meinhard Schiller
Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.
European journal of dermatology : EJD 2008;18(1):29-35.
2007: Stefan Beissert; Thomas Werfel; Uta Frieling; Markus Böhm; Michael Sticherling; Rudolf Stadler; Detlef Zillikens; Berthold Rzany; Nicolas Hunzelmann; Michael Meurer; Harald Gollnick; Thomas Ruzicka; Hans Pillekamp; Volker Junghans; Gisela Bonsmann; Thomas A Luger
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Archives of dermatology 2007;143(12):1536-42.
2007: Marcel Lucas Müller; Andrea Forschner; Thomas A Luger; Rainer Rompel; Norbert Roeder; Peter Hensen
[G-DRG version 2007: a short overview].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2007;5(9):778-87.
2007: Thomas E Scholzen; Simone Koenig; Michaela Fastrich; Markus Böhm; Thomas A Luger
Terminating the stress: peripheral peptidolysis of proopiomelanocortin-derived regulatory hormones by the dermal microvascular endothelial cell extracellular peptidases neprilysin and angiotensin-converting enzyme.
Endocrinology 2007;148(6):2793-805.
2007: Carsten Weishaupt; Dieter Metze; Thomas A Luger; Sonja Ständer
Treatment of pustular psoriasis with infliximab.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2007;5(5):397-9.
2007: Markus Böhm; Thomas A Luger
Lichen planus responding to efalizumab.
Journal of the American Academy of Dermatology 2007;56(5 Suppl):S92-3.
2007: Stefan W Schneider; Markus Gaubitz; Thomas A Luger; Gisela Bonsmann
Prompt response of refractory Schnitzler syndrome to treatment with anakinra.
Journal of the American Academy of Dermatology 2007;56(5 Suppl):S120-2.
2007: Sonja Ständer; Hartmut Ständer; Stephan Seeliger; Thomas A Luger; Martin Steinhoff
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin.
The British journal of dermatology 2007;156(5):1020-6.
2007: H Lan Ma; Dieter Metze; Thomas A Luger; Martin Steinhoff
Successful treatment of generalized eruptive histiocytoma with PUVA.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2007;5(2):131-4.
2007: Franz Sommer; Peter Hensen; Barbara Böckenholt; Dieter Metze; Thomas A Luger; Sonja Ständer
Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study.
Acta dermato-venereologica 2007;87(6):510-6.
2007: Sonja Ständer; Elke Weisshaar; Thomas Mettang; Jacek C Szepietowski; Earl Carstens; Akihiko Ikoma; Nora V Bergasa; Uwe Gieler; Laurent Misery; Joanna Wallengren; Ulf Darsow; Markus Streit; Dieter Metze; Thomas A Luger; Malcolm W Greaves; Martin Schmelz; Gil Yosipovitch; Jeffrey D Bernhard
Clinical classification of itch: a position paper of the International Forum for the Study of Itch.
Acta dermato-venereologica 2007;87(4):291-4.
2007: Dorothée Nashan; D Faulhaber; Sonja Ständer; Thomas A Luger; Rudolf Stadler
Mycosis fungoides: a dermatological masquerader.
The British journal of dermatology 2007;156(1):1-10.
2006: Stefan Beissert; Thomas Werfel; Uta Frieling; Markus Böhm; Michael Sticherling; Rudolf Stadler; Detlef Zillikens; Berthold Rzany; Nicolas Hunzelmann; Michael Meurer; Harald Gollnick; Thomas Ruzicka; Hans Pillekamp; Volker Junghans; Thomas A Luger
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Archives of dermatology 2006;142(11):1447-54.
2006: Gudrun Schneider; Georg Driesch; Gereon Heuft; S Evers; Thomas A Luger; Sonja Ständer
Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch.
Clinical and experimental dermatology 2006;31(6):762-7.
2006: Simone Koenig; Thomas A Luger; Thomas E Scholzen
Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin.
Experimental dermatology 2006;15(10):751-61.
2006: Christian Maaser; K Kannengiesser; C Specht; Andreas Lügering; Thomas Brzoska; Thomas A Luger; Wolfram Domschke; Torsten Kucharzik
Crucial role of the melanocortin receptor MC1R in experimental colitis.
Gut 2006;55(10):1415-22.
2006: Markus Böhm; Thomas A Luger; Desmond J Tobin; José C García-Borrón
Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.
The Journal of investigative dermatology 2006;126(9):1966-75.
2006: Sonja Ständer; H W Reinhardt; Thomas A Luger
[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2006;57(9):801-7.
2006: Tobias Goerge; Alexej Barg; Eva-Maria Schnaeker; Birgit Poppelmann; Victoria M Shpacovitch; Anke Rattenholl; Christian Maaser; Thomas A Luger; Martin Steinhoff; Stefan W Schneider
Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.
Cancer research 2006;66(15):7766-74.
2006: Martin Steinhoff; Antje Steinhoff; Bernhard Homey; Thomas A Luger; Stefan W Schneider
Role of vasculature in atopic dermatitis.
The Journal of allergy and clinical immunology 2006;118(1):190-7.
2006: Sonja Ständer; Funda Schürmeyer-Horst; Thomas A Luger; Elke Weisshaar
Treatment of pruritic diseases with topical calcineurin inhibitors.
Therapeutics and clinical risk management 2006;2(2):213-8.
2006: Peter Hensen; Marcel Lucas Müller; Johannes Petres; Thomas A Luger; Harald Gollnick
[Current situation of dermatologic surgery in Germany].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2006;4(6):477-85.
2006: Karin Loser; Sandra Balkow; Tetsuya Higuchi; Jenny Apelt; Annegret Kuhn; Thomas A Luger; Stefan Beissert
FK506 controls CD40L-induced systemic autoimmunity in mice.
The Journal of investigative dermatology 2006;126(6):1307-15.
2006: Christian Gorzelanny; Tobias Goerge; Eva-Maria Schnaeker; Kai Thomas; Thomas A Luger; Stefan W Schneider
Atomic force microscopy as an innovative tool for nanoanalysis of native stratum corneum.
Experimental dermatology 2006;15(5):387-91.
2006: Meinhard Schiller; Dieter Metze; Thomas A Luger; Stephan Grabbe; Matthias Gunzer
Immune response modifiers--mode of action.
Experimental dermatology 2006;15(5):331-41.
2006: Corinna Moormann; Metin Artuc; Elena Pohl; Georg Varga; Jörg Buddenkotte; Nathalie Vergnolle; Randolf Brehler; Beate M Henz; Stefan W Schneider; Thomas A Luger; Martin Steinhoff
Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells.
The Journal of investigative dermatology 2006;126(4):746-55.
2006: Meinhard Schiller; Markus Böhm; Peter Hensen; Helge Riemann; Thomas A Luger; Dorothée Nashan
Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?
Journal of the American Academy of Dermatology 2006;54(2):221-6.
2006: Markus Böhm; Meinhard Schiller; Thomas A Luger
Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.
Cellular and molecular biology (Noisy-le-Grand, France) 2006;52(2):61-8.
2006: Stefan W Schneider; Sonja Staender; Bernhard Schlüter; Thomas A Luger; Gisela Bonsmann
Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis.
Archives of dermatology 2006;142(1):115-6.
2006: G Schneider; J Hockmann; Sonja Ständer; Thomas A Luger; Gereon Heuft
Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study.
The British journal of dermatology 2006;154(1):61-6.
2006: Mathias B W Krummen; Georg Varga; Meike Steinert; Anton Stuetz; Thomas A Luger; Stephan Grabbe
Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function.
Experimental dermatology 2006;15(1):43-50.
2005: Peter Hensen; Holger Bunzemeier; Rainer Rompel; Thomas A Luger; Wolfram Sterry; Norbert Roeder
[Inpatient dermatology: appropriateness of admissions and G-AEP].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2005;3(11):927-36.
2005: Vinzenz Oji; G Beljan; K Beier; Heiko Traupe; Thomas A Luger
Topical pimecrolimus: a novel therapeutic option for Netherton syndrome.
The British journal of dermatology 2005;153(5):1067-8.
2005: Markus Böhm; Mareike Eickelmann; Zhuo Li; Stefan W Schneider; Vinzenz Oji; Sven Diederichs; Gregory S Barsh; Annika Vogt; Karola Stieler; Ulrike Blume-Peytavi; Thomas A Luger
Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of alpha-melanocyte-stimulating hormone in human dermal papilla cells.
Endocrinology 2005;146(11):4635-46.
2005: Elke Weisshaar; Thomas L Diepgen; Thomas A Luger; Stephan Seeliger; Ralf Witteler; Sonja Ständer
Pruritus in pregnancy and childhood--do we really consider all relevant differential diagnoses?
European journal of dermatology : EJD 2005;15(5):320-31.
2005: Peter Hensen; Torsten Fürstenberg; Thomas A Luger; Martin Steinhoff; Norbert Roeder
Case mix measures and diagnosis-related groups: opportunities and threats for inpatient dermatology.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(5):582-8.
2005: Thomas A Luger; Stefan Beissert
[Daily relations with UV and prevention of photoaging of skin -- introduction to the topic].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2005;3 Suppl 2():S1-2.
2005: Carmen Loquai; Dieter Metze; Dorothée Nashan; Thomas A Luger; Markus Böhm
Confetti-like lesions with hyperkeratosis: a novel ultraviolet-induced hypomelanotic disorder?
The British journal of dermatology 2005;153(1):190-3.
2005: Peter Hensen; Huong-Lan Ma; Thomas A Luger; Norbert Roeder; Martin Steinhoff
Pathway management in ambulatory wound care: defining local standards for quality improvement and interprofessional care.
International wound journal 2005;2(2):104-11.
2005: Peter Hensen; Torsten Fürstenberg; Meinhard Schiller; Thomas A Luger; Rainer Rompel; Norbert Roeder
[G-dRG version 2005: relevant aspects for dermatology].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2005;3(3):169-80.
2005: Markus Böhm; Ilka Wolff; Thomas E Scholzen; Samantha J Robinson; Eugene Healy; Thomas A Luger; Thomas Schwarz; Agatha Schwarz
alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage.
The Journal of biological chemistry 2005;280(7):5795-802.
2005: Martin Steinhoff; Jörg Buddenkotte; Victoria M Shpacovitch; Anke Rattenholl; Corinna Moormann; Nathalie Vergnolle; Thomas A Luger; Morley D Hollenberg
Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
Endocrine reviews 2005;26(1):1-43.
2005: Peter Hensen; Christian Juhra; Ansgar Rausch; Silke Wollert; Thomas A Luger; Norbert Roeder
[Introduction of quality management with the EFQM Self-Assessment method. Implementation and experience in a university department of dermatology].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2005;99(9):531-6.
2005: Jörg Buddenkotte; Christopher Stroh; Ingo H Engels; Corinna Moormann; Victoria M Shpacovitch; Stephan Seeliger; Nathalie Vergnolle; Dietmar Vestweber; Thomas A Luger; Klaus Schulze-Osthoff; Martin Steinhoff
Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.
The Journal of investigative dermatology 2005;124(1):38-45.
2005: Elke Weisshaar; Ralf Witteler; Thomas L Diepgen; Thomas A Luger; Sonja Ständer
[Pruritus in pregnancy. A frequent diagnostic and therapeutic challenge].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2005;56(1):48-57.
2004: A Brune; Dieter Metze; Thomas A Luger; Sonja Ständer
[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(12):1130-6.
2004: Zhuo Li; Dieter Metze; Dorothea Nashan; Carsten Müller-Tidow; Hubert Serve; Christopher Poremba; Thomas A Luger; Markus Böhm
Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.
The Journal of investigative dermatology 2004;123(4):737-45.
2004: Christian Schachtrup; Thomas E Scholzen; Veronika Grau; Thomas A Luger; Clemens Sorg; Friedrich Spener; Claus Kerkhoff
L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: evidence for a PPARalpha-independent expression.
The international journal of biochemistry & cell biology 2004;36(10):2042-53.
2004: Elke Weisshaar; Stephan Seeliger; Thomas L Diepgen; Thomas A Luger; Sonja Ständer
[Pruritus in childhood. A diagnostic and therapeutic challenge].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(9):855-68.
2004: Victoria M Shpacovitch; Georg Varga; Anke Strey; Matthias Gunzer; Frank Mooren; Jörg Buddenkotte; Nathalie Vergnolle; Christian P Sommerhoff; Stephan Grabbe; Volker Gerke; B Homey; Morley D Hollenberg; Thomas A Luger; Martin Steinhoff
Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices.
Journal of leukocyte biology 2004;76(2):388-98.
2004: Peter Hensen; Holger Bunzemeier; Torsten Fürstenberg; Thomas A Luger; Bernhard Rochell; Norbert Roeder
[Ambulatory procedures to replace inpatient care. Background and applications].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(7):667-75.
2004: Thomas E Scholzen; Martin Steinhoff; Anca Sindrilaru; Agatha Schwarz; Nigel W Bunnett; Thomas A Luger; Cheryl A Armstrong; John C Ansel
Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(9):1007-9.
2004: M Böhm; Thomas A Luger
[Alpha-melanocyte-stimulating hormone. Its current significance for dermatology].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(5):436-45.
2004: Sonja Ständer; Corinna Moormann; Mark Schumacher; Jörg Buddenkotte; Metin Artuc; Victoria M Shpacovitch; Thomas Brzoska; Undine Lippert; Beate M Henz; Thomas A Luger; Dieter Metze; Martin Steinhoff
Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.
Experimental dermatology 2004;13(3):129-39.
2004: Markus Böhm; Michael Raghunath; Cord Sunderkötter; Meinhard Schiller; Sonja Ständer; Thomas Brzoska; Thomas Cauvet; Helgi B Schiöth; Thomas Schwarz; Thomas A Luger
Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone.
The Journal of biological chemistry 2004;279(8):6959-66.
2004: Meinhard Schiller; Thomas Brzoska; Markus Böhm; Dieter Metze; Thomas E Scholzen; André Rougier; Thomas A Luger
Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo.
The Journal of investigative dermatology 2004;122(2):468-76.
2004: Carmen Loquai; Dorothée Nashan; Dieter Metze; U Beiteke; K W Rüping; Thomas A Luger; Stephan Grabbe
[Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(2):176-81.
2004: Torsten Fürstenberg; Rainer Rompel; Harald Gollnick; Wolfram Sterry; Thomas A Luger; Peter Hensen; Norbert Roeder
[DRGs in dermatology: results of the DRG evaluation project of the German Society of Dermatology (DDG)].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2004;2(1):24-30.
2004: Peter Hensen; Torsten Fürstenberg; Sebastian Irps; Stephan Grabbe; Thomas Schwarz; Thomas A Luger; Rainer Rompel; Norbert Roeder
[G-DRG Version 2004: changes in view of dermatology].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2004;2(1):15-23.
2004: Thomas E Scholzen; Thomas A Luger
Neutral endopeptidase and angiotensin-converting enzyme -- key enzymes terminating the action of neuroendocrine mediators.
Experimental dermatology 2004;13 Suppl 4():22-6.
2004: Markus Böhm; Thomas A Luger
Melanocortins in fibroblast biology--current update and future perspective for dermatology.
Experimental dermatology 2004;13 Suppl 4():16-21.
2004: Anita Ruetter; Thomas A Luger
Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current view.
American journal of clinical dermatology 2004;5(3):153-60.
2003: Uta Frieling; Gisela Bonsmann; Thomas Schwarz; Thomas A Luger; Stefan Beissert
Treatment of severe lichen planus with mycophenolate mofetil.
Journal of the American Academy of Dermatology 2003;49(6):1063-6.
2003: Sonja Ständer; Hartmut Ständer; H Kutzner; Thomas A Luger; Dieter Metze
[Squamous epithelial carcinomas of the face with neurotropic growth].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2003;54(11):1087-94.
2003: Stephan Seeliger; Claudia K Derian; Nathalie Vergnolle; Nigel W Bunnett; Roman Nawroth; Martin Schmelz; Pierre-Yves von der Weid; Jörg Buddenkotte; Cord Sunderkötter; Dieter Metze; Patricia Andrade-Gordon; Erik Harms; Dietmar Vestweber; Thomas A Luger; Martin Steinhoff
Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(13):1871-85.
2003: Martin Steinhoff; Ulrich Neisius; Akihiko Ikoma; Manige Fartasch; Gisela Heyer; Per Stahl Skov; Thomas A Luger; Martin Schmelz
Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(15):6176-80.
2003: Markus Böhm; Uta Frieling; Thomas A Luger; Gisela Bonsmann
Successful treatment of anogenital lichen sclerosus with topical tacrolimus.
Archives of dermatology 2003;139(7):922-4.
2003: Thomas A Luger; Thomas E Scholzen; Thomas Brzoska; Markus Böhm
New insights into the functions of alpha-MSH and related peptides in the immune system.
Annals of the New York Academy of Sciences 2003;994():133-40.
2003: Sonja Ständer; Thomas A Luger
[Antipruritic effects of pimecrolimus and tacrolimus].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2003;54(5):413-7.
2003: Thomas E Scholzen; Sonja Ständer; Helge Riemann; Thomas Brzoska; Thomas A Luger
Modulation of cutaneous inflammation by angiotensin-converting enzyme.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(7):3866-73.
2003: Markus Böhm; Markus Gaubitz; Thomas A Luger; Dieter Metze; Gisela Bonsmann
Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases.
Dermatology (Basel, Switzerland) 2003;207(4):381-5.
2003: Thomas E Scholzen; Cord Sunderkötter; DH Kalden; Thomas Brzoska; Michaela Fastrich; T Fisbeck; Cheryl A Armstrong; John C Ansel; Thomas A Luger
Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression.
Endocrinology 2003;144(1):360-70.
2002: Sonja Ständer; Hans-Georg Bone; H G Machens; T Aberle; W Burchard; Thomas Prien; Thomas A Luger; Dieter Metze
Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals.
Cell and tissue research 2002;310(3):279-87.
2002: Thomas A Luger
Neuromediators--a crucial component of the skin immune system.
Journal of dermatological science 2002;30(2):87-93.
2002: Uta Frieling; Thomas A Luger
Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
Clinical and experimental dermatology 2002;27(7):562-70.
2002: K Assmann; Dorothée Nashan; Stephan Grabbe; Thomas A Luger; Dieter Metze
[Persistent inflammatory reaction at the injection site of Il-2 with lymphoma-like inflammatory infiltrates].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2002;53(8):554-7.
2002: Markus Böhm; Peter Fritz Schmidt; Bernd Lödding; Holger Uphoff; Gerald W Westermann; Thomas A Luger; Gisela Bonsmann; Dieter Metze
Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence.
The American Journal of dermatopathology 2002;24(4):345-50.
2002: DH Kalden; Thomas Brzoska; Thomas Schwarz; A Richard; A Rougier; Thomas A Luger
UV-induced production of immunosuppressive mediators in human skin: prevention by a broadspectrum sunscreen.
European journal of dermatology : EJD 2002;12(4):XV-XVI.
2002: Anita Rütter; Thomas A Luger
Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Current opinion in investigational drugs (London, England : 2000) 2002;3(5):713-9.
2002: Markus Böhm; Meinhard Schiller; Sonja Ständer; Holger Seltmann; Zhuo Li; Thomas Brzoska; Dieter Metze; Helgi B Schiöth; Anna Skottner; Kristina Seiffert; Christos Zouboulis; Thomas A Luger
Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ.
The Journal of investigative dermatology 2002;118(3):533-9.
2002: Victoria M Shpacovitch; Thomas Brzoska; Jörg Buddenkotte; Christopher Stroh; Christian P Sommerhoff; John C Ansel; Klaus Schulze-Osthoff; Nigel W Bunnett; Thomas A Luger; Martin Steinhoff
Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells.
The Journal of investigative dermatology 2002;118(2):380-5.
2001: Cord Sunderkötter; Stephan Seeliger; Frank Schönlau; Johannes Roth; Rupert Hallmann; Thomas A Luger; Clemens Sorg; G Kolde
Different pathways leading to cutaneous leukocytoclastic vasculitis in mice.
Experimental dermatology 2001;10(6):391-404.
2001: Annette Mehling; Karin Loser; Georg Varga; Dieter Metze; Thomas A Luger; Thomas Schwarz; Stephan Grabbe; Stefan Beissert
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.
The Journal of experimental medicine 2001;194(5):615-28.
2001: Meinhard Schiller; M Böhm; Cornelia Zeidler; Manuela Germeshausen; Karl Welte; Thomas A Luger; Gisela Bonsmann
[Cyclic neutropenia. Detection of a mutation in the gene for neutrophil elastase (ELA2)].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2001;52(9):790-6.
2001: Meinhard Schiller; Michael Raghunath; Ulrich Kubitscheck; Thomas E Scholzen; T Fisbeck; Dieter Metze; Thomas A Luger; Markus Böhm
Human dermal fibroblasts express prohormone convertases 1 and 2 and produce proopiomelanocortin-derived peptides.
The Journal of investigative dermatology 2001;117(2):227-35.
2001: Markus Böhm; U Schulte; J O Funk; Michael Raghunath; Iris Behrmann; Marcin Kortylewski; Peter C Heinrich; Thorsten Kues; Thomas A Luger; Thomas Schwarz
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
The Journal of investigative dermatology 2001;117(1):132-40.
2001: Anita Rütter; Thomas A Luger
High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Journal of the American Academy of Dermatology 2001;44(6):1010-24.
2001: Gisela Bonsmann; Meinhard Schiller; Thomas A Luger; Sonja Ständer
Terbinafine-induced subacute cutaneous lupus erythematosus.
Journal of the American Academy of Dermatology 2001;44(6):925-31.
2001: Sonja Ständer; Zsolt Szépfalusi; B Bohle; Hartmut Ständer; D Kraft; Thomas A Luger; Dieter Metze
Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study.
Cell and tissue research 2001;304(2):261-9.
2001: Martin Steinhoff; Dieter Metze; E Stockfleth; Thomas A Luger
Successful topical treatment of focal epithelial hyperplasia (Heck's disease) with interferon-beta.
The British journal of dermatology 2001;144(5):1067-9.
2001: Markus Böhm; Meinhard Schiller; Dorothée Nashan; R Stadler; Thomas A Luger; Dieter Metze
Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors.
Journal of the American Academy of Dermatology 2001;44(5):747-54.
2001: Thomas E Scholzen; Martin Steinhoff; Paola Bonaccorsi; R Klein; Silvia Amadesi; P Geppetti; B Lu; N P Gerard; John E Olerud; Thomas A Luger; Nigel W Bunnett; Eileen F Grady; Cheryl A Armstrong; John C Ansel
Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):1285-91.
2000: Markus Böhm; Burkhard Riemann; Thomas A Luger; Gisela Bonsmann
Bilateral upper limb lymphoedema associated with psoriatic arthritis: a case report and review of the literature.
The British journal of dermatology 2000;143(6):1297-301.
2000: Thomas E Scholzen; DH Kalden; Thomas Brzoska; T Fisbeck; Michaela Fastrich; Meinhard Schiller; Markus Böhm; Thomas Schwarz; Cheryl A Armstrong; John C Ansel; Thomas A Luger
Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1.
The Journal of investigative dermatology 2000;115(6):1021-8.
2000: Annette Mehling; Stephan Grabbe; Maik Voskort; Thomas Schwarz; Thomas A Luger; Stefan Beissert
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(5):2374-81.
2000: Markus Böhm; Thomas A Luger
The role of melanocortins in skin homeostasis.
Hormone research 2000;54(5-6):287-93.
2000: Thomas A Luger; Thomas Brzoska; Thomas E Scholzen; DH Kalden; Cord Sunderkötter; C Armstrong; John C Ansel
The role of alpha-MSH as a modulator of cutaneous inflammation.
Annals of the New York Academy of Sciences 2000;917():232-8.
1999: Stefan Beissert; Jeffrey A Bluestone; I Mindt; Maik Voskort; Dieter Metze; Annette Mehling; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6725-31.
1999: Markus Böhm; Dieter Metze; U Schulte; Eva Becher; Thomas A Luger; Thomas Brzoska
Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ.
Experimental dermatology 1999;8(6):453-61.
1999: Thomas E Scholzen; Thomas Brzoska; DH Kalden; M Hartmeyer; Thomas A Luger; Cheryl A Armstrong; John C Ansel
Expression of proopiomelanocortin peptides and prohormone convertases by human dermal microvascular endothelial cells.
Annals of the New York Academy of Sciences 1999;885():444-7.
1999: Dieter Metze; S Reimann; Thomas A Luger
Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
Annals of the New York Academy of Sciences 1999;885():430-2.
1999: Cord Sunderkötter; H Kalden; Thomas Brzoska; Clemens Sorg; Thomas A Luger
alpha-MSH reduces vasculitis in the local Shwartzman reaction.
Annals of the New York Academy of Sciences 1999;885():414-8.
1999: Markus Böhm; Thomas Brzoska; U Schulte; Meinhard Schiller; Ulrich Kubitscheck; Thomas A Luger
Characterization of a polyclonal antibody raised against the human melanocortin-1 receptor.
Annals of the New York Academy of Sciences 1999;885():372-82.
1999: Markus Böhm; U Schulte; H Kalden; Thomas A Luger
Alpha-melanocyte-stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts.
Annals of the New York Academy of Sciences 1999;885():277-86.
1999: DH Kalden; Thomas E Scholzen; Thomas Brzoska; Thomas A Luger
Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression.
Annals of the New York Academy of Sciences 1999;885():254-61.
1999: Thomas E Scholzen; Thomas Brzoska; DH Kalden; M Hartmeyer; Michaela Fastrich; Thomas A Luger; Cheryl A Armstrong; John C Ansel
Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells.
Annals of the New York Academy of Sciences 1999;885():239-53.
1999: Thomas Brzoska; DH Kalden; Thomas E Scholzen; Thomas A Luger
Molecular basis of the alpha-MSH/IL-1 antagonism.
Annals of the New York Academy of Sciences 1999;885():230-8.
1999: Thomas A Luger; Thomas Schwarz; H Kalden; Thomas E Scholzen; Agatha Schwarz; Thomas Brzoska
Role of epidermal cell-derived alpha-melanocyte stimulating hormone in ultraviolet light mediated local immunosuppression.
Annals of the New York Academy of Sciences 1999;885():209-16.
1999: Eva Becher; K Mahnke; Thomas Brzoska; DH Kalden; Stephan Grabbe; Thomas A Luger
Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R.
Annals of the New York Academy of Sciences 1999;885():188-95.
1999: G Kothny-Wilkes; Dagmar Kulms; Thomas A Luger; M Kubin; Thomas Schwarz
Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis.
The Journal of biological chemistry 1999;274(41):28916-21.
1999: Dorothée Nashan; Thomas A Luger
[Interleukin 1. Part 2: Mode of action and therapeutic possibilities].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1999;50(10):756-63.
1999: Thomas E Scholzen; Thomas Brzoska; DH Kalden; Fiona M O'Reilly; Cheryl A Armstrong; Thomas A Luger; John C Ansel
Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1999;4(1):55-60.
1999: Dorothée Nashan; Thomas A Luger
[Interleukin 1. 1: Basic principles and pathophysiology].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1999;50(9):680-8.
1999: Markus Böhm; Thomas A Luger; Dieter Metze
[Acanthosis nigricans associated with transitional cell carcinoma of the bladder--symptomatic treatment with calcipotriol].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1999;50(8):593-6.
1999: Dagmar Kulms; Birgit Pöppelmann; D Yarosh; Thomas A Luger; Jean Krutmann; Thomas Schwarz
Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(14):7974-9.
1999: C Curiel-Lewandrowski; K Mahnke; M Labeur; B Roters; W Schmidt; Richard D Granstein; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):174-83.
1999: S Müller; Stefan Beissert; Dieter Metze; Thomas A Luger; Gisela Bonsmann
Lipodystrophia centrifugalis abdominalis infantilis in a 4-year-old Caucasian girl: association with partial IgA deficiency and autoantibodies.
The British journal of dermatology 1999;140(6):1161-4.
1999: S Beissert; Dagmar Presser; Anita Rütter; Dieter Metze; Thomas A Luger; Thomas Schwarz
[Embolia cutis medicamentosa (Nicolau syndrome) after intra-articular injection].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1999;50(3):214-6.
1999: Markus Böhm; Thomas A Luger; Gisela Bonsmann
Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol.
Journal of the American Academy of Dermatology 1999;40(3):479-80.
1999: Thomas A Luger; DH Kalden; Thomas E Scholzen; Thomas Brzoska
alpha-melanocyte-stimulating hormone as a mediator of tolerance induction.
Pathobiology : journal of immunopathology, molecular and cellular biology 1999;67(5-6):318-21.
1999: Markus Böhm; Thomas A Luger
Cutaneous neuroimmunomodulation: the proopiomelanocortin system. A New York Academy of Sciences Conference, September 11-13, 1998, Münster, Germany.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(3):225-8.
1999: S Wustlich; Randolf Brehler; Thomas A Luger; T Pohle; Wolfram Domschke; Ernst Christoph Foerster
Helicobacter pylori as a possible bacterial focus of chronic urticaria.
Dermatology (Basel, Switzerland) 1999;198(2):130-2.
1999: M S Labeur; B Roters; B Pers; Annette Mehling; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):168-75.
1998: Stefan Beissert; Hai-Tao He; Anne-Odile Hueber; A C Lellouch; Dieter Metze; Annette Mehling; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
Impaired cutaneous immune responses in Thy-1-deficient mice.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(10):5296-302.
1998: G Kothny-Wilkes; Dagmar Kulms; Birgit Pöppelmann; Thomas A Luger; M Kubin; Thomas Schwarz
Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand.
The Journal of biological chemistry 1998;273(44):29247-53.
1998: Thomas E Scholzen; M Hartmeyer; Michaela Fastrich; Thomas Brzoska; Eva Becher; Thomas Schwarz; Thomas A Luger
Ultraviolet light and interleukin-10 modulate expression of cytokines by transformed human dermal microvascular endothelial cells (HMEC-1).
The Journal of investigative dermatology 1998;111(1):50-6.
1998: Thomas A Luger; T Lotti
Neuropeptides: role in inflammatory skin diseases.
Journal of the European Academy of Dermatology and Venereology : JEADV 1998;10(3):207-11.
1998: Thomas A Luger; Thomas E Scholzen; Thomas Brzoska; Eva Becher; A Slominski; R Paus
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone.
Annals of the New York Academy of Sciences 1998;840():381-94.
1998: Agatha Schwarz; Stephan Grabbe; Karin Grosse-Heitmeyer; B Roters; Helge Riemann; Thomas A Luger; Giorgio Trinchieri; Thomas Schwarz
Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(9):4262-70.
1998: Thomas A Luger
Immunomodulation by UV light: role of neuropeptides.
European journal of dermatology : EJD 1998;8(3):198-9.
1998: Thomas E Scholzen; Cheryl A Armstrong; Nigel W Bunnett; Thomas A Luger; John E Olerud; John C Ansel
Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems.
Experimental dermatology 1998;7(2-3):81-96.
1998: Jean Krutmann; T L Diepgen; Thomas A Luger; S Grabbe; H Meffert; N Sönnichsen; Wolfgang Czech; A Kapp; Helger Stege; Markus Grewe; Erwin Schöpf
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.
Journal of the American Academy of Dermatology 1998;38(4):589-93.
1998: Agatha Schwarz; Stephan Grabbe; K Mahnke; Helge Riemann; Thomas A Luger; Maria Wysocka; Giorgio Trinchieri; Thomas Schwarz
Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells.
The Journal of investigative dermatology 1998;110(3):272-6.
1998: Yoshinori Aragane; Dagmar Kulms; D Metze; G Wilkes; Birgit Pöppelmann; Thomas A Luger; Thomas Schwarz
Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
The Journal of cell biology 1998;140(1):171-82.
1998: Markus Böhm; Thomas A Luger
The pilosebaceous unit is part of the skin immune system.
Dermatology (Basel, Switzerland) 1998;196(1):75-9.
1998: M G Haufs; Stefan Beissert; Stephan Grabbe; B Schütte; Thomas A Luger
Psoriasis vulgaris treated successfully with mycophenolate mofetil.
The British journal of dermatology 1998;138(1):179-81.
1997: Birgitta Kütting; M Böhm; Thomas A Luger; Gisela Bonsmann
Oropharyngeal lichen planus associated with interferon-alpha treatment for mycosis fungoides: a rare side-effect in the therapy of cutaneous lymphomas.
The British journal of dermatology 1997;137(5):836-7.
1997: Yoshinori Aragane; Dagmar Kulms; Thomas A Luger; Thomas Schwarz
Down-regulation of interferon gamma-activated STAT1 by UV light.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11490-5.
1997: Cord Sunderkötter; H Kalden; Thomas A Luger
Aging and the skin immune system.
Archives of dermatology 1997;133(10):1256-62.
1997: M Hartmeyer; Thomas E Scholzen; Eva Becher; R S Bhardwaj; Thomas Schwarz; Thomas A Luger
Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(4):1930-7.
1997: Thomas A Luger; Thomas E Scholzen; Stephan Grabbe
The role of alpha-melanocyte-stimulating hormone in cutaneous biology.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1997;2(1):87-93.
1997: Randolf Brehler; A Hildebrand; Thomas A Luger
Recent developments in the treatment of atopic eczema.
Journal of the American Academy of Dermatology 1997;36(6 Pt 1):983-94.
1997: Yoshinori Aragane; Agatha Schwarz; Thomas A Luger; Kiyoshi Ariizumi; Akira Takashima; Thomas Schwarz
Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(11):5393-9.
1997: Dieter Metze; S Reimann; Z Szepfalusi; B Bohle; D Kraft; Thomas A Luger
Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves.
The British journal of dermatology 1997;136(4):553-9.
1997: R Bhardwaj; Eva Becher; K Mahnke; M Hartmeyer; Thomas Schwarz; Thomas E Scholzen; Thomas A Luger
Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(7):3378-84.
1997: Agatha Schwarz; K Mahnke; Thomas A Luger; Thomas Schwarz
Pentoxifylline reduces the formation of sunburn cells.
Experimental dermatology 1997;6(1):1-5.
1997: Birgitta Kütting; Gisela Bonsmann; Dieter Metze; Thomas A Luger; L Cerroni
Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a.
Journal of the American Academy of Dermatology 1997;36(2 Pt 2):311-4.
1997: K Mahnke; Eva Becher; P Ricciardi-Castagnoli; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide.
Advances in experimental medicine and biology 1997;417():145-59.
1996: Dieter Metze; Thomas A Luger
Ultrastructural localization of carcinoembryonic antigen (CEA) glycoproteins and epithelial membrane antigen (EMA) in normal and neoplastic sweat glands.
Journal of cutaneous pathology 1996;23(6):518-29.
1996: Thomas A Luger; R S Bhardwaj; Stephan Grabbe; Thomas Schwarz
Regulation of the immune response by epidermal cytokines and neurohormones.
Journal of dermatological science 1996;13(1):5-10.
1996: K Mahnke; R S Bhardwaj; Thomas A Luger; Thomas Schwarz; Stephan Grabbe
Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines.
Journal of leukocyte biology 1996;60(4):465-72.
1996: Stephan Grabbe; M Steinert; K Mahnke; A Schwartz; Thomas A Luger; Thomas Schwarz
Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.
The Journal of clinical investigation 1996;98(5):1158-64.
1996: Jacek Malejczyk; M Malejczyk; F Breitburd; Slawomir Majewski; A Schwarz; N Expert-Besançon; Stefania Jablonska; G Orth; Thomas A Luger
Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.
British journal of cancer 1996;74(2):234-9.
1996: Yoshinori Aragane; H Yamada; Agatha Schwarz; B Poppelmann; Thomas A Luger; T Tezuka; Thomas Schwarz
Transforming growth factor-alpha induces interleukin-6 in the human keratinocyte cell line HaCaT mainly by transcriptional activation.
The Journal of investigative dermatology 1996;106(6):1192-7.
1996: Agatha Schwarz; Stephan Grabbe; Yoshinori Aragane; K Sandkuhl; Helge Riemann; Thomas A Luger; M Kubin; Trinchieri Giorgio; Thomas Schwarz
Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance.
The Journal of investigative dermatology 1996;106(6):1187-91.
1996: Birgitta Kütting; Dieter Metze; Thomas A Luger; Gisela Bonsmann
Mycosis fungoides presenting as an acquired ichthyosis.
Journal of the American Academy of Dermatology 1996;34(5 Pt 2):887-9.
1996: R S Bhardwaj; Agatha Schwarz; Eva Becher; K Mahnke; Yoshinori Aragane; Thomas Schwarz; Thomas A Luger
Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(7):2517-21.
1996: Helge Riemann; Agatha Schwarz; Stephan Grabbe; Yoshinori Aragane; Thomas A Luger; Maria Wysocka; M Kubin; G Trinchieri; Thomas Schwarz
Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(5):1799-803.
1996: U Theissen; Thomas A Luger; Thomas Schwarz
[Successful topical administration of cyclosporin A in pyoderma gangraenosum].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1996;47(2):132-5.
1996: Dieter Metze; Fritz Grunert; Michael Neumaier; R Bhardwaj; U Amann; C Wagener; Thomas A Luger
Neoplasms with sweat gland differentiation express various glycoproteins of the carcinoembryonic antigen (CEA) family.
Journal of cutaneous pathology 1996;23(1):1-11.
1996: Stephan Grabbe; R S Bhardwaj; K Mahnke; M M Simon; Thomas Schwarz; Thomas A Luger
alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(2):473-8.
1996: Dieter Metze; R Bhardwaj; U Amann; A M Eades-Perner; Michael Neumaier; C Wagener; Peter Jantscheff; Fritz Grunert; Thomas A Luger
Glycoproteins of the carcinoembryonic antigen (CEA) family are expressed in sweat and sebaceous glands of human fetal and adult skin.
The Journal of investigative dermatology 1996;106(1):64-9.
1995: Stephan Grabbe; K Steinbrink; M Steinert; Thomas A Luger; Thomas Schwarz
Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(9):4207-17.
1995: A Hildebrand; Gerhard Kolde; Thomas A Luger; Thomas Schwarz
Successful treatment of generalized lichen planus with recombinant interferon alfa-2b.
Journal of the American Academy of Dermatology 1995;33(5 Pt 2):880-3.
1995: Thomas A Luger
Cytokine treatment of mast-cell-mediated skin diseases.
Experimental dermatology 1995;4(4 Pt 2):277-80.
1995: L Kretzschmar; K Biel; Thomas A Luger; Sergij Goerdt
[Generalized granuloma annulare or diffuse dermal histiocytosis?].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1995;46(8):561-7.
1995: Agatha Schwarz; R Bhardwaj; Yoshinori Aragane; K Mahnke; Helge Riemann; Dieter Metze; Thomas A Luger; Thomas Schwarz
Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells.
The Journal of investigative dermatology 1995;104(6):922-7.
1995: C Mohr; Cord Sunderkötter; A Hildebrand; K Biel; A Rütter; G H Rütter; Thomas A Luger; Gerhard Kolde
Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins.
The British journal of dermatology 1995;132(5):824-6.
1995: M M Simon; A Reikerstorfer; Agatha Schwarz; C Krone; Thomas A Luger; M Jäättelä; Thomas Schwarz
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release.
The Journal of clinical investigation 1995;95(3):926-33.
1995: L Kretzschmar; Gisela Bonsmann; Dieter Metze; Thomas A Luger; T Schwarz
[Scarring psoriatic alopecia].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1995;46(3):154-7.
1995: C Mohr; B Schütte; A Hildebrand; Thomas A Luger; Gerhard Kolde
Eosinophilic pustular folliculitis: successful treatment with interferon-alpha.
Dermatology (Basel, Switzerland) 1995;191(3):257-9.
1994: Yoshinori Aragane; Helge Riemann; R S Bhardwaj; Agatha Schwarz; Y Sawada; H Yamada; Thomas A Luger; M Kubin; G Trinchieri; Thomas Schwarz
IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(12):5366-72.
1994: P Neuner; Gabriele Klosner; E Schauer; M Pourmojib; W Macheiner; C Grünwald; Robert Knobler; Agatha Schwarz; Thomas A Luger; Thomas Schwarz
Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells.
Immunology 1994;83(2):262-7.
1994: Agatha Schwarz; Stephan Grabbe; Helge Riemann; Yoshinori Aragane; M Simon; S Manon; S Andrade; Thomas A Luger; Albert Zlotnik; Thomas Schwarz
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions.
The Journal of investigative dermatology 1994;103(2):211-6.
1994: E Schauer; Franz Trautinger; A Köck; Agatha Schwarz; R Bhardwaj; M Simon; John C Ansel; Thomas Schwarz; Thomas A Luger
Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes.
The Journal of clinical investigation 1994;93(5):2258-62.
1994: M M Simon; Yoshinori Aragane; Agatha Schwarz; Thomas A Luger; Thomas Schwarz
UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts.
The Journal of investigative dermatology 1994;102(4):422-7.
1994: Jacek Malejczyk; M Malejczyk; Slawomir Majewski; F Breitburd; Thomas A Luger; Stefania Jablonska; G Orth
Increased tumorigenicity of human keratinocytes harboring human papillomavirus type 16 is associated with resistance to endogenous tumor necrosis factor-alpha-mediated growth limitation.
International journal of cancer. Journal international du cancer 1994;56(4):593-8.
1994: P Neuner; B Charvat; Robert Knobler; Reinhard Kirnbauer; Agatha Schwarz; Thomas A Luger; Thomas Schwarz
Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A.
Photochemistry and photobiology 1994;59(2):182-8.
1994: R S Bhardwaj; Thomas A Luger
Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis.
Archives of dermatological research 1994;287(1):85-90.
1993: Stefan Beissert; U Koch; Cord Sunderkötter; Thomas A Luger; Thomas Schwarz
Successful treatment of disseminated verrucae vulgares with interferon-beta.
Journal of the American Academy of Dermatology 1993;29(6):1041-2.
1993: C Mohr; P Duschet; Gisela Bonsmann; Thomas A Luger; F Gschnait; Thomas Schwarz
[Dyshidrosiform bullous pemphigoid].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1993;44(12):785-8.
1993: Agatha Schwarz; C Krone; Franz Trautinger; Yoshinori Aragane; P Neuner; Thomas A Luger; Thomas Schwarz
Pentoxifylline suppresses irritant and contact hypersensitivity reactions.
The Journal of investigative dermatology 1993;101(4):549-52.
1993: Stefan Beissert; Dieter Metze; Thomas A Luger; Thomas Schwarz
[Pemphigus herpetiformis].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1993;44(9):594-7.
1993: Franz Trautinger; I Trautinger; Ingela Kindas-Mügge; Dieter Metze; Thomas A Luger
Human keratinocytes in vivo and in vitro constitutively express the 72-kD heat shock protein.
The Journal of investigative dermatology 1993;101(3):334-8.
1993: U Trefzer; M Brockhaus; H Lötscher; F Parlow; A Budnik; Markus Grewe; H Christoph; A Kapp; Erwin Schöpf; Thomas A Luger
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation.
The Journal of clinical investigation 1993;92(1):462-70.
1993: Thomas A Luger; E Schauer; Franz Trautinger; Jean Krutmann; John C Ansel; Agatha Schwarz; Thomas Schwarz
Production of immunosuppressing melanotropins by human keratinocytes.
Annals of the New York Academy of Sciences 1993;680():567-70.
1993: Zsolt Szépfalusi; E Parth; W Jurecka; Thomas A Luger; Dietrich Kraft
Human monocytes and keratinocytes in culture ingest hydroxyethylstarch.
Archives of dermatological research 1993;285(3):144-50.
1992: Jacek Malejczyk; M Malejczyk; A Köck; A Urbanski; Slawomir Majewski; Nicolas Hunzelmann; Stefania Jablonska; G Orth; Thomas A Luger
Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(8):2702-8.
1992: Cheryl A Armstrong; D C Tara; CE Hart; A Köck; Thomas A Luger; John C Ansel
Heterogeneity of cytokine production by human malignant melanoma cells.
Experimental dermatology 1992;1(1):37-45.
1992: Jacek Malejczyk; M Malejczyk; A Urbanski; Thomas A Luger
Production of natural killer cell activity-augmenting factor (interleukin-6) by human epiphyseal chondrocytes.
Arthritis and rheumatism 1992;35(6):706-13.
1992: Jean Krutmann; Wolfgang Czech; F Parlow; U Trefzer; A Kapp; Erwin Schöpf; Thomas A Luger
Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway.
The Journal of investigative dermatology 1992;98(6):923-8.
1992: Reinhard Kirnbauer; B Charvat; E Schauer; A Köck; A Urbanski; Eckart Förster; P Neuner; I Assmann; Thomas A Luger; Thomas Schwarz
Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light.
The Journal of investigative dermatology 1992;98(3):320-6.
1991: Jacek Malejczyk; M Malejczyk; A Urbanski; A Köck; Stefania Jablonska; G Orth; Thomas A Luger
Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells.
Cellular immunology 1991;136(1):155-64.
1991: P Neuner; A Urbanski; Franz Trautinger; A Möller; Reinhard Kirnbauer; A Kapp; Erwin Schöpf; Thomas Schwarz; Thomas A Luger
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis.
The Journal of investigative dermatology 1991;97(1):27-33.
1991: Thomas A Luger; Thomas Schwarz
Therapeutic use of cytokines in dermatology.
Journal of the American Academy of Dermatology 1991;24(6 Pt 1):915-26.
1991: Reinhard Kirnbauer; A Köck; P Neuner; Eckart Förster; Jean Krutmann; A Urbanski; E Schauer; John C Ansel; Thomas Schwarz; Thomas A Luger
Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids.
The Journal of investigative dermatology 1991;96(4):484-9.
1991: A Kapp; P Neuner; Jean Krutmann; Thomas A Luger; Erwin Schöpf
Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
Acta dermato-venereologica 1991;71(5):403-6.
1990: A Köck; Thomas Schwarz; Reinhard Kirnbauer; A Urbanski; P Perry; John C Ansel; Thomas A Luger
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.
The Journal of experimental medicine 1990;172(6):1609-14.
1990: Thomas A Luger; Thomas Schwarz
Evidence for an epidermal cytokine network.
The Journal of investigative dermatology 1990;95(6 Suppl):100S-104S.
1990: W Borth; B Scheer; A Urbansky; Thomas A Luger; L Sottrup-Jensen
Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(11):3747-54.
1990: Slawomir Majewski; Jacek Malejczyk; A Urbanski; T Schwarz; M Malejczyk; J Misiewicz; L Rudnicka; J Szymańczyk; Thomas A Luger; S Jabłońska
[Studies on the production of epidermal cytokines after UVB irradiation in patients with epidermodysplasia verruciformis].
Przegla̧d dermatologiczny 1990;77(6):389-91.
1990: Jean Krutmann; Thomas Schwarz; Reinhard Kirnbauer; A Urbanski; Thomas A Luger
Epidermal cell-contra-interleukin 1 inhibits human accessory cell function by specifically blocking interleukin 1 activity.
Photochemistry and photobiology 1990;52(4):783-8.
1990: Jean Krutmann; Reinhard Kirnbauer; A Köck; Thomas Schwarz; Erwin Schöpf; L T May; P B Sehgal; Thomas A Luger
Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(5):1337-42.
1990: Jean Krutmann; A Köck; E Schauer; F Parlow; A Möller; A Kapp; Eckart Förster; Erwin Schöpf; Thomas A Luger
Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression.
The Journal of investigative dermatology 1990;95(2):127-31.
1990: W Borth; A Urbanski; R Prohaska; M Susanj; Thomas A Luger
Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes.
Blood 1990;75(12):2388-95.
1990: A Urbanski; Thomas Schwarz; P Neuner; Jean Krutmann; Reinhard Kirnbauer; A Köck; Thomas A Luger
Ultraviolet light induces increased circulating interleukin-6 in humans.
The Journal of investigative dermatology 1990;94(6):808-11.
1990: Thomas A Luger; Thomas Schwarz; Jean Krutmann; A Köck; A Urbanski; Reinhard Kirnbauer
Cytokines and the skin.
Current problems in dermatology 1990;19():35-49.
1989: Thomas A Luger; Jean Krutmann; Reinhard Kirnbauer; A Urbanski; Thomas Schwarz; G Klappacher; A Köck; Michael Micksche; Jacek Malejczyk; E Schauer
IFN-beta 2/IL-6 augments the activity of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(4):1206-9.
1989: W Borth; Thomas A Luger
Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.
The Journal of biological chemistry 1989;264(10):5818-25.
1989: Reinhard Kirnbauer; A Köck; Thomas Schwarz; A Urbanski; Jean Krutmann; W Borth; D Damm; G Shipley; John C Ansel; Thomas A Luger
IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(6):1922-8.
1989: A Köck; Thomas Schwarz; A Urbanski; Z Peng; Monika Vetterlein; Michael Micksche; John C Ansel; H F Kung; Thomas A Luger
Expression and release of interleukin-1 by different human melanoma cell lines.
Journal of the National Cancer Institute 1989;81(1):36-42.
1989: A Kapp; R Kirnbauer; Thomas A Luger; Erwin Schöpf
Altered production of immuno-modulating cytokines in patients with atopic dermatitis.
Acta dermato-venereologica. Supplementum 1989;144():97-9.
1989: Thomas A Luger
Epidermal cytokines.
Acta dermato-venereologica. Supplementum 1989;151():61-76; discussion 106-10.
1989: Thomas A Luger
Interferons and cytokines.
Current problems in dermatology 1989;18():269-76.
1989: Thomas A Luger; Thomas Schwarz; Jean Krutmann; Reinhard Kirnbauer; P Neuner; A Köck; A Urbanski; W Borth; E Schauer
Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells.
Annals of the New York Academy of Sciences 1989;557():405-14.
1988: Thomas Schwarz; A Urbanski; Reinhard Kirnbauer; A Köck; F Gschnait; Thomas A Luger
Detection of a specific inhibitor of interleukin 1 in sera of UVB-treated mice.
The Journal of investigative dermatology 1988;91(6):536-40.
1988: A Kapp; G Zeck-Kapp; M Danner; Thomas A Luger
Human granulocyte-macrophage colony stimulating factor: an effective direct activator of human polymorphonuclear neutrophilic granulocytes.
The Journal of investigative dermatology 1988;91(1):49-55.
1988: Anton Luger; Guntram Schernthaner; A Urbanski; Thomas A Luger
Cytokine production in patients with newly diagnosed insulin-dependent (type I) diabetes mellitus.
European journal of clinical investigation 1988;18(3):233-6.
1988: Thomas A Luger; A Kock; Reinhard Kirnbauer; Thomas Schwarz; John C Ansel
Keratinocyte-derived interleukin 3.
Annals of the New York Academy of Sciences 1988;548():253-61.
1987: A Kapp; M Danner; Thomas A Luger; C Hauser; Erwin Schöpf
Granulocyte-activating mediators (GRAM). II. Generation by human epidermal cells--relation to GM-CSF.
Archives of dermatological research 1987;279(7):470-7.
1986: A Köck; M Danner; Beda Stadler; Thomas A Luger
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1.
The Journal of experimental medicine 1986;163(2):463-8.
1985: Thomas A Luger; A Köck; M Danner; M Colot; Michael Micksche
Production of distinct cytokines by epidermal cells.
The British journal of dermatology 1985;113 Suppl 28():145-56.
1985: Thomas A Luger; A Köck; M Danner
Characterization of immunoregulatory cytokines produced by epidermal cells.
Scandinavian journal of immunology 1985;21(5):455-62.
1985: Thomas A Luger; A Uchida; A Köck; M Colot; Michael Micksche
Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(4):2477-83.
1983: Thomas A Luger; J A Charon; M Colot; Michael Micksche; J J Oppenheim
Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(2):816-20.